Literature DB >> 18591091

Clinical, pathologic and genetic studies on autosomal recessive early-onset parkinsonism with diurnal fluctuation.

Y Yamamura1, S Kuzuhara, K Kondo, T Yanagi, M Uchida, H Matsumine, Y Mizuno.   

Abstract

To clarify the genetic mode and clinical characteristics of familial early-onset parkinsonism with diurnal fluctuation, we studied 43 patients from 22 families. The estimated segregation ratio (0.2963) and absence of gender preponderance indicated autosomal recessive inheritance. Clinical features included the average age at onset of 26.1 years, parkinsonism with marked diurnal fluctuation, remarkable effect of levodopa, dyskinesias, dystonia, hyperreflexia, absence of dementia, and a benign course; autonomic symptoms were only mild if present. Autopsy study in one of our patients disclosed neuronal loss without Lewy bodies and the presence of melanin-poor neurons in the substantia nigra. Linkage analysis on 16 families mapped the disease gene to chromosome 6q25.2-27.

Entities:  

Year:  1998        PMID: 18591091     DOI: 10.1016/s1353-8020(98)00015-7

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  14 in total

Review 1.  Update on the pathology of dystonia.

Authors:  David G Standaert
Journal:  Neurobiol Dis       Date:  2011-01-08       Impact factor: 5.996

2.  A Peruvian family with a novel PARK2 mutation: Clinical and pathological characteristics.

Authors:  Mario R Cornejo-Olivas; Luis Torres; Ignacio F Mata; Pilar Mazzetti; Diana Rivas; Carlos Cosentino; Miguel Inca-Martinez; Juan M Cuba; Cyrus P Zabetian; James B Leverenz
Journal:  Parkinsonism Relat Disord       Date:  2015-01-15       Impact factor: 4.891

Review 3.  Twenty years since the discovery of the parkin gene.

Authors:  Nobutaka Hattori; Yoshikuni Mizuno
Journal:  J Neural Transm (Vienna)       Date:  2017-06-15       Impact factor: 3.575

Review 4.  Neuropathology of genetic synucleinopathies with parkinsonism: Review of the literature.

Authors:  Susanne A Schneider; Roy N Alcalay
Journal:  Mov Disord       Date:  2017-11       Impact factor: 10.338

Review 5.  The neuropathology of genetic Parkinson's disease.

Authors:  Markos Poulopoulos; Oren A Levy; Roy N Alcalay
Journal:  Mov Disord       Date:  2012-03-26       Impact factor: 10.338

6.  BAG2 prevents Tau hyperphosphorylation and increases p62/SQSTM1 in cell models of neurodegeneration.

Authors:  Raquel S Lima; Daniel C Carrettiero; Merari F R Ferrari
Journal:  Mol Biol Rep       Date:  2022-05-25       Impact factor: 2.742

Review 7.  α-Synuclein oligomers and clinical implications for Parkinson disease.

Authors:  Lorraine V Kalia; Suneil K Kalia; Pamela J McLean; Andres M Lozano; Anthony E Lang
Journal:  Ann Neurol       Date:  2012-12-07       Impact factor: 10.422

8.  Genetic neuropathology of Parkinson's disease.

Authors:  Mark R Cookson; John Hardy; Patrick A Lewis
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

9.  Parkin and PINK1 parkinsonism may represent nigral mitochondrial cytopathies distinct from Lewy body Parkinson's disease.

Authors:  J Eric Ahlskog
Journal:  Parkinsonism Relat Disord       Date:  2009-10-07       Impact factor: 4.891

10.  Parkin disease: a clinicopathologic entity?

Authors:  Karen M Doherty; Laura Silveira-Moriyama; Laura Parkkinen; Daniel G Healy; Michael Farrell; Niccolo E Mencacci; Zeshan Ahmed; Francesca M Brett; John Hardy; Niall Quinn; Timothy J Counihan; Timothy Lynch; Zoe V Fox; Tamas Revesz; Andrew J Lees; Janice L Holton
Journal:  JAMA Neurol       Date:  2013-05       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.